Annual Symposium of the AHA Basic Cardiovascular Sciences Council

描述（由申请人提供）：这是美国心脏协会基础心血管科学理事会年度夏季研讨会的新申请。 在过去的8年里，这次会议一直得到NHLBI的支持，去年获得了R13 HL 078309的资助。 来自NHLBI的支持帮助促成了一次会议，该会议已成为处理分子心血管生物学和疾病的“去”会议。 它代表其赞助者，美国心脏协会基础心血管科学理事会，这是世界领先的心血管科学家组织。这个会议最初开始于二十年前，当时理事会于1991年举行了一次分子心脏病学会议，然后举行了几次会议，最初被称为雪鸟会议，因为它是在夏天在犹他州的雪鸟举行的。 该会议于2002年成为年度活动，自2004年以来，该会议已被公认为AHA的永久性，经常性的科学会议，R13资金也开始。近年来的会议已经开始混合在翻译的主题以及这个会议的“面包和黄油”，这是基础分子心血管研究。 该会议一直吸引着microRNA，心脏基因和细胞治疗以及线粒体调控等领域的领先研究人员。 该会议的出席人数每年都在攀升，去年（2011年）在新奥尔良举行的会议有534名注册与会者，创下了历史记录。与往年一样，会议将于7月举行，并将再次在新奥尔良举行。 计划的议程是一个雄心勃勃的，快节奏的会议，在4天内（2012年7月23日至26日）举行了14次会议。今年的会议将在新奥尔良滨江的希尔顿酒店举行，并由尤金布劳恩沃尔德博士和山中伸弥博士发表两个备受瞩目的主题演讲。 年轻的心血管科学家也将通过每场会议的邀请演讲得到强调 海报将在会议的三天内展示。 本次会议的组织者是 Drs.王一斌（加州大学洛杉矶分校），安娜罗莎莱里（BWH，哈佛）和罗杰哈贾尔（山。Sinai）。提案申请约占会议总预算的7%，在过去几年中，该申请的支持将用于心血管外展奖（少数群体差旅奖）和新研究者差旅奖。公共卫生相关性：本提案旨在支持美国心脏协会基础心血管科学理事会年会。该会议每年7月举行，由基础和转化心血管科学家参加，该领域的科学交流处于最高水平。 这次会议和类似的会议可以加速与心脏病新疗法有关的发现，这是非常需要的。这次会议是一个伟大的学习经验，为年轻的科学家和学员，从而优化未来的回报投资医学研究的公共资金。

DESCRIPTION (provided by applicant): This is a new application for the Annual Summer Symposium of the Basic Cardiovascular Sciences Council of the American Heart Association. This conference has had continuous support from the NHLBI for the last 8 years and last year was funded with the grant number of R13 HL078309. Support from the NHLBI has helped foster a meeting that has become the "go to" conference dealing with molecular cardiovascular biology and disease. It represents its sponsor, the Council on Basic Cardiovascular Sciences of the American Heart Association, which is the world's leading organization of cardiovascular scientists. This conference started originally two decades ago as the Council held a Molecular Cardiology conference in 1991 and then had several meetings initially hailed as the Snowbird Conference as it was held during the summer at Snowbird, Utah. The meeting became an annual event in 2002 and since 2004 this conference has been recognized as a permanent, recurring scientific meeting of the AHA and R13 funding also commenced. The conference in recent years has begun to mix in translational topics as well as the "bread and butter" of this meeting, which is basic molecular cardiovascular research. The conference has always attracted the leading researchers in fields such as microRNAs, cardiac gene and cell therapy and mitochondrial regulation. The attendance of this conference has climbed every year and last year (2011) the conference held in New Orleans had an all-time record attendance with 534 registered attendees. As in past years, the conference will be held in July and will once again be in New Orleans. The planned agenda represents an ambitious, fast-paced meeting with 14 sessions over 4 days (July 23-26, 2012). This year the meeting will be held at The Hilton New Orleans Riverside and have 2 high-profile Keynote lectures given by Dr. Eugene Braunwald and Dr. Shinya Yamanaka. Young cardiovascular scientists will be highlighted as well through invited talks in each session and Posters will be presented on 3 days of the conference. Organizers of this meeting are Drs. Yibin Wang (UCLA), Annarosa Leri (BWH, Harvard) and Roger Hajjar (Mt. Sinai). The proposal request constitutes approximately 7% of the total meeting budget and as over the last several years, support from this application will be used toward Cardiovascular Outreach Awards (minority travel awards) and New Investigator Travel Awards. PUBLIC HEALTH RELEVANCE: This proposal is for support of the annual conference of the Basic Cardiovascular Sciences Council of the American Heart Association. This meeting meets every July and is attended by basic and translational cardiovascular scientists where scientific exchange in this field is at its highest level. This meeting and those like it can accelerae discoveries pertinent to new therapies for heart disease, which are greatly needed. This meeting is a great learning experience for junior scientists and trainees and thus, optimizes the future return of investment in medical research by public dollars.